-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
bioAffinity Technologies, Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2021 to 31 Mar 2025.
- bioAffinity Technologies, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $1,641,775, a 30% increase year-over-year.
- bioAffinity Technologies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $7,264,795, a 20% decline from 2023.
- bioAffinity Technologies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $6,037,806, a 48% decline from 2022.
- bioAffinity Technologies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $4,070,845, a 99% decline from 2021.